T1D to 100 | Aging With Diabetes
Home 9 How Will Your Body Change? 9 Glucose Highs and Lows

High Blood Sugars:  Why Are “Sticky” Highs Difficult to Treat as We Age?

Managing hyperglycemia (high blood sugar) becomes more challenging for individuals with Type 1 diabetes (T1D) as they age due to changes in insulin sensitivity, physical activity levels, and other health factors.

Why It’s More Difficult to Treat Hyperglycemia with Age

  1. Decreased Insulin Sensitivity: Aging can reduce how effectively cells respond to insulin, leading to higher blood sugar levels despite appropriate dosing. Chronic inflammation and hormonal changes may exacerbate insulin resistance.
  2. Slower Absorption of Insulin: Peripheral circulation often declines with age, which can delay the absorption of subcutaneous insulin, prolonging high blood sugar episodes.
  3. Comorbidities: Age-related conditions like kidney disease or heart disease can complicate insulin management and exacerbate hyperglycemia.
  4. Polypharmacy: The use of multiple medications for other health issues can interact with diabetes treatments, potentially increasing glucose levels.
  5. Reduced Physical Activity: Lower activity levels in older adults can decrease the body’s ability to utilize glucose efficiently, contributing to stubborn hyperglycemia.

Strategies for Managing Stubborn Hyperglycemia

  • Adjusting Insulin Regimens:
    • Use faster-acting insulins, such as Lispro or Aspart, which can help correct blood sugar more quickly.
    • Inhaled insulin (e.g., Afrezza) may offer rapid correction in some cases, particularly for those with delayed subcutaneous absorption.
  • Technology Integration:
    • Continuous glucose monitors (CGMs) provide real-time data, helping to identify patterns of persistent hyperglycemia and allowing for more precise insulin dosing.
    • Automated insulin delivery systems can adjust basal rates dynamically based on glucose trends.
  • Improving Insulin Sensitivity:
    • Light to moderate exercise, if safe and feasible, can enhance glucose uptake.
    • Diet modifications, such as reducing high-glycemic-index foods, can prevent prolonged elevations in glucose levels.
    • If tolerated and prescribed by your medical physician, medications such as Metformin, GLP-1s, and SGLT-2s can help improve insulin sensitivity.
  • Personalized Care:
    • Frequent consultation with a healthcare provider is crucial to adjust insulin doses, meal timing, and other aspects of the treatment plan.
    • Assessment for conditions like gastroparesis, which can delay glucose absorption and insulin action, is important.
  • Addressing Stress and Hormonal Factors:
    • Stress management strategies can mitigate cortisol-related blood sugar spikes.
    • Monitoring for the “dawn phenomenon” (early morning glucose rise) may guide adjustments to evening insulin dosing.

These approaches aim to minimize risks associated with high blood sugar while maintaining quality of life in older individuals with T1D.

Hypoglycemia:  Symptoms and Treatments CHANGE as We Age with T1D

Hypoglycemia in individuals with Type 1 Diabetes (T1D) can become increasingly complex as we age due to changes in physiology, medication use, and overall health. Here’s a breakdown of the symptoms, therapies, and considerations associated with hypoglycemia in older adults with T1D, as well as why it takes longer to correct low blood sugar in this population.

Changes in Symptoms of Hypoglycemia with Age

  • Reduced Hypoglycemia Awareness
  • Aging and long-term diabetes can impair the autonomic response that triggers warning symptoms like sweating, shakiness, or a rapid heartbeat.
  • This condition, called hypoglycemia unawareness, increases the risk of severe lows, as the individual may not recognize the early signs of hypoglycemia.
  • Subtle or Atypical Symptoms
    • Older adults may experience non-traditional symptoms such as confusion, dizziness, or falls, which might be mistaken for other health issues.
  • Cognitive Changes
    • Aging can be accompanied by cognitive decline, making it harder for older individuals to recognize, report, or treat hypoglycemia promptly.
  • Therapeutic Challenges and Considerations

    1. Delayed Absorption of Glucose
      • Older adults often have slower gastric emptying, which can delay the absorption of glucose or other carbohydrates consumed to treat a low blood sugar episode.
    2. Impaired Liver Function
      • The liver’s ability to release stored glucose (glycogen) in response to hypoglycemia may diminish with age, reducing the body’s ability to self-correct.
    3. Comorbidities and Polypharmacy
      • Conditions like kidney disease, heart disease, or neuropathy can affect blood sugar levels and complicate treatment.
      • Medications such as beta-blockers can blunt hypoglycemia symptoms, making detection harder.
    4. Insulin Sensitivity Changes
      • Decreased physical activity and changes in body composition can lead to insulin resistance or sensitivity, affecting how blood sugar is managed.

    Longer Recovery Time for Hypoglycemia in Older Adults

    1. Slower Metabolism
      • Aging slows down metabolic processes, which can lengthen the time it takes for ingested carbohydrates to raise blood sugar levels.
    2. Limited Glycogen Reserves
      • Older individuals may have reduced glycogen stores in the liver due to aging or poor nutrition, hindering the body’s ability to respond quickly to low blood sugar.
    3. Reduced Counterregulatory Hormonal Response
      • Aging and prolonged diabetes reduce the secretion of hormones like glucagon and epinephrine, which are critical for raising blood sugar.
    4. Delayed Reaction Times
      • Older adults may take longer to act on low blood sugar symptoms, further extending recovery time.

    Management Strategies for Older T1D Patients

    1. Frequent Monitoring
      • Continuous glucose monitors (CGMs) can provide real-time alerts for low blood sugar, helping prevent severe hypoglycemia. Simplified Treatment Protocols
      • Pre-measured glucose tablets or gels can ensure proper and efficient correction of low blood sugar without guesswork.
    2. Individualized Targets
      • Less stringent blood sugar targets may be appropriate to reduce the risk of hypoglycemia in older adults. For example, it can be helpful to raise the Low Alert level on your CGM to 80 or 85, rather than lower levels you might have used in the past, such as 70, so that you can get ahead of a rapidly dropping glucose level.
    3. Education and Support
      • Regular training for patients and caregivers about recognizing and managing hypoglycemia is essential.
    4. Dietary Adjustments
      • Consistent carbohydrate intake, particularly around exercise and bedtime, can help stabilize blood sugar levels.

    Conclusion

    As people with T1D age, the management of hypoglycemia requires greater vigilance and a tailored approach to account for physiological changes and comorbidities. Slower glucose absorption, reduced hormonal responses, and cognitive challenges are key reasons why it takes longer to correct hypoglycemia in older adults. By adapting therapies and incorporating supportive tools like CGMs, the risks of hypoglycemia can be minimized, ensuring a better quality of life for aging individuals with T1D.

    📚 Additional Resources Regarding Hyper/Hypoglycemia

    Glucagon, from past to present: A century of intensive research and controversies

    This article, published in The Lancet Diabetes & Endocrinology in February 2023, reviews the 100-year history of glucagon, a hormone that plays a key role in regulating blood sugar and metabolism.

    The article traces the discovery, structure, and function of glucagon, including its production in the pancreas and how it works by stimulating the liver to release glucose. It explains how glucagon acts as a natural counterbalance to insulin, especially during periods of low blood sugar, fasting, and physical stress. The authors highlight glucagon’s essential role in both type 1 and type 2 diabetes, including its contribution to high blood sugar and its use in treating severe hypoglycemia.

    Additionally, the article discusses therapeutic developments that target glucagon, including glucagon receptor blockers, GLP-1-based medications, and newer co-agonist drugs, which aim to improve blood sugar control and promote weight loss. Overall, the article portrays glucagon as a hormone with a complex legacy—both a cause of and a potential solution for metabolic diseases.

    Altered Responses to Hypoglycemia of Healthy Elderly People

    This article, published in Diabetes Research and Clinical Practice in January 2024, explores how older adults with type 1 or type 2 diabetes begin using and incorporating continuous glucose monitoring (CGM) devices into their daily lives. Despite the known health benefits of CGM, older adults often face more challenges in adopting the technology, including physical, cognitive, and emotional barriers.

    The researchers developed a detailed model that describes six key phases of CGM integration—from deciding to try the device to becoming fully reliant on it. They used interviews with 17 older adults and 3 caregivers to refine the model, focusing on the experiences, beliefs, and support needs at each stage. The study also identifies strategies—like emotional support and personalized training—that could help older adults succeed with CGM. The goal is to guide better, more tailored support for this growing population as diabetes technology becomes more widespread.

    Perioperative Hyperglycemia Management: An Update

    This article, “Perioperative Hyperglycemia Management: An Update”, published in Anesthesiology in March 2017, provides a detailed overview of how to manage high blood sugar (hyperglycemia) in people undergoing surgery. The authors emphasize that elevated blood glucose around the time of surgery is common and can lead to worse outcomes, including infections, longer hospital stays, and higher mortality.

    The article explains how surgical stress, anesthesia, and fasting all disrupt normal glucose control, especially in patients with diabetes. It reviews the best practices for monitoring and treating hyperglycemia before, during, and after surgery using insulin, and outlines recommended blood sugar targets. The authors also discuss newer medications, insulin pump use, and strategies to prevent hypoglycemia. Overall, the article serves as a comprehensive guide for healthcare professionals to improve glucose control in surgical patients and reduce complications.

    Continuous Glucose Monitoring in Aging T1Ds with Hypoglycemia

    Read FREE with registration

    This study, published in Diabetes Care, a journal of the American Diabetes Association, on September 26, 2024, examined how the use of CGMs, combined with personalized care, can help older adults manage T1D more safely. The research included 131 people aged 65+, all living with T1D and at risk for hypoglycemia. Half the group used CGMs and received personalized care from specialists trained in caring for older adults. The other half continued their usual diabetes care with their regular doctors.

    After six months, the group with the CGMs and special care spent significantly less time with dangerously low blood sugar levels—about 2.6% less—compared to just 0.3% less in the regular care group. Importantly, their overall blood sugar control stayed stable, and the approach was found to be cost-effective in terms of health benefits.

    Automated Insulin Delivery in Older Adults with Type 1 Diabetes

    A study published in NEJM Evidence on March 4, 2024, explored how well automated insulin delivery (AID) systems work for older adults with type 1 diabetes. While they’ve already proven helpful in younger populations, it wasn’t clear if they were just as safe and effective for older adults, who often face additional health challenges.

    Eighty-two participants between 65 and 86 years of age completed three 12-week periods of using hybrid closed loop (Tandem t:slim X2 with Control-IQ), predictive low-glucose suspend (Tandem t:slim X2 with Basal-IQ), and sensor-augmented pump (Tandem t:slim X2 in manual mode) insulin delivery in a randomized order.

    Researchers found that using an AID system helped participants keep their blood sugar within the recommended range for more of the day—without increasing the risk of low blood sugar. The older adults in the study were able to use the technology successfully and experienced better overall diabetes control. In short, the study suggests that AID systems are both safe and effective for older adults, and may help them manage diabetes more easily and safely.

    (Access to full article requires subscription to NEJM)

    Altered Responses to Hypoglycemia

    Requires site registration to view abstract, fee for full access

    Abstract of a research paper highlighting factors that may lead to hypoglycemia in aging adults. Subscription required to download full paper.

    Last updated 2025-08-20.

    Recent Stories